223 related articles for article (PubMed ID: 2167436)
21. Mobility of endogenous ecotropic murine leukemia viral genomes within mouse chromosomal DNA and integration of a mink cell focus-forming virus-type recombinant provirus in the germ line.
Quint W; van der Putten H; Janssen F; Berns A
J Virol; 1982 Mar; 41(3):901-8. PubMed ID: 6284980
[TBL] [Abstract][Full Text] [Related]
22. Fim-1, Fim-2/c-fms, and Fim-3, three common integration sites of Friend murine leukemia virus in myeloblastic leukemias, map to mouse chromosomes 13, 18, and 3, respectively.
Sola B; Simon D; Mattéi MG; Fichelson S; Bordereaux D; Tambourin PE; Guenet JL; Gisselbrecht S
J Virol; 1988 Nov; 62(11):3973-8. PubMed ID: 2902233
[TBL] [Abstract][Full Text] [Related]
23. Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1.
Shaughnessy JD; Largaespada DA; Tian E; Fletcher CF; Cho BC; Vyas P; Jenkins NA; Copeland NG
Oncogene; 1999 Mar; 18(12):2069-84. PubMed ID: 10321731
[TBL] [Abstract][Full Text] [Related]
24. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.
Moreau-Gachelin F; Tavitian A; Tambourin P
Nature; 1988 Jan; 331(6153):277-80. PubMed ID: 2827041
[TBL] [Abstract][Full Text] [Related]
25. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
Largaespada DA
Leukemia; 2000 Jul; 14(7):1174-84. PubMed ID: 10914539
[TBL] [Abstract][Full Text] [Related]
26. Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias.
Bergeron D; Houde J; Poliquin L; Barbeau B; Rassart E
Leukemia; 1993 Jul; 7(7):954-62. PubMed ID: 8391616
[TBL] [Abstract][Full Text] [Related]
27. The EVI-1 gene--its role in pathogenesis of human leukemias.
Jółkowska J; Witt M
Leuk Res; 2000 Jul; 24(7):553-8. PubMed ID: 10867128
[TBL] [Abstract][Full Text] [Related]
28. Transplacental transmission of a leukemogenic murine leukemia virus.
Bedigian HG; Shepel LA; Hoppe PC
J Virol; 1993 Oct; 67(10):6105-9. PubMed ID: 8396671
[TBL] [Abstract][Full Text] [Related]
29. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of Evi1, a zinc finger oncogene involved in myeloid leukemia.
Lopingco MC; Perkins AS
Curr Top Microbiol Immunol; 1996; 211():211-22. PubMed ID: 8585952
[TBL] [Abstract][Full Text] [Related]
31. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1.
Oval J; Smedsrud M; Taetle R
Leukemia; 1992 May; 6(5):446-51. PubMed ID: 1593910
[TBL] [Abstract][Full Text] [Related]
32. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.
Ben-David Y; Giddens EB; Bernstein A
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1332-6. PubMed ID: 2304901
[TBL] [Abstract][Full Text] [Related]
33. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene.
Bartholomew C; Morishita K; Askew D; Buchberg A; Jenkins NA; Copeland NG; Ihle JN
Oncogene; 1989 May; 4(5):529-34. PubMed ID: 2542863
[TBL] [Abstract][Full Text] [Related]
34. fim-1 and fim-2: two new integration regions of Friend murine leukemia virus in myeloblastic leukemias.
Sola B; Fichelson S; Bordereaux D; Tambourin PE; Gisselbrecht S
J Virol; 1986 Nov; 60(2):718-25. PubMed ID: 3464762
[TBL] [Abstract][Full Text] [Related]
35. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.
Mukhopadhyaya R; Wolff L
J Virol; 1992 Oct; 66(10):6035-44. PubMed ID: 1527851
[TBL] [Abstract][Full Text] [Related]
36. Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas.
Chattopadhyay SK; Cloyd MW; Linemeyer DL; Lander MR; Rands E; Lowy DR
Nature; 1982 Jan; 295(5844):25-31. PubMed ID: 6276750
[No Abstract] [Full Text] [Related]
37. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
[TBL] [Abstract][Full Text] [Related]
38. Abnormal expression of Evi-1 gene in human leukemias.
Ogawa S; Mitani K; Kurokawa M; Matsuo Y; Minowada J; Inazawa J; Kamada N; Tsubota T; Yazaki Y; Hirai H
Hum Cell; 1996 Dec; 9(4):323-32. PubMed ID: 9183665
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs.
Bordereaux D; Fichelson S; Tambourin P; Gisselbrecht S
Oncogene; 1990 Jun; 5(6):925-7. PubMed ID: 2113669
[TBL] [Abstract][Full Text] [Related]
40. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
